Bristol Myers Squibb just doubled down on AI power with a second NVIDIA supercomputer—delivering ten times the performance per watt to slash energy costs and accelerate drug discovery. This upgrade, part of a three-year partnership, lets them screen dozens of drug candidates instead of just ten, speeding up research for cancer, heart disease, and more. By building their own AI foundation models using proprietary data and NVIDIA’s biological AI platform, they’re creating a global, unified computing environment to tackle complex medical challenges faster than ever.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
